<ol class="cite-this-references"><li id="reference-A188354">Werumeus Buning J, Touw DJ, Brummelman P, Dullaart RPF, van den Berg G, van der Klauw MM, Kamp J, Wolffenbuttel BHR, van Beek AP: Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial. Metabolism. 2017 Jun;71:7-16. doi: 10.1016/j.metabol.2017.02.005. Epub 2017 Feb 13. [<a href="/articles/A188354" target="_blank">Article</a>] </li><li id="reference-A188372">Aalto-Korte K, Turpeinen M: Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol. 1995 Aug;133(2):259-63. doi: 10.1111/j.1365-2133.1995.tb02625.x. [<a href="/articles/A188372" target="_blank">Article</a>] </li><li id="reference-A188375">Aalto-Korte K, Turpeinen M: Quantifying systemic absorption of topical hydrocortisone in erythroderma. Br J Dermatol. 1995 Sep;133(3):403-8. doi: 10.1111/j.1365-2133.1995.tb02668.x. [<a href="/articles/A188375" target="_blank">Article</a>] </li><li id="reference-A188378">Lima JJ, Jusko WJ: Bioavailability of hydrocortisone retention enemas in relation to absorption kinetics. Clin Pharmacol Ther. 1980 Aug;28(2):262-9. doi: 10.1038/clpt.1980.159. [<a href="/articles/A188378" target="_blank">Article</a>] </li><li id="reference-A184223">FLORINI JR, BUYSKE DA: Plasma protein binding of triamcinolone-H3 and hydrocortisone-4-C14. J Biol Chem. 1961 Jan;236:247-51. [<a href="/articles/A184223" target="_blank">Article</a>] </li><li id="reference-A188381">Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M: Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol. 1991 May;31(5):473-6. doi: 10.1002/j.1552-4604.1991.tb01906.x. [<a href="/articles/A188381" target="_blank">Article</a>] </li><li id="reference-A188387">Jung C, Greco S, Nguyen HH, Ho JT, Lewis JG, Torpy DJ, Inder WJ: Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. BMC Endocr Disord. 2014 Nov 26;14:91. doi: 10.1186/1472-6823-14-91. [<a href="/articles/A188387" target="_blank">Article</a>] </li><li id="reference-A188405">Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E: Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S94-8. doi: 10.4103/0976-500X.120975. [<a href="/articles/A188405" target="_blank">Article</a>] </li><li id="reference-A188420">Simoni R, Hill R, Vaughan M: The Isolation of Thyroxine and Cortisone: the Work of Edward C. Kendall Journal of Biological Chemistry. 2002 May 24;277(21):e10. [<a href="/articles/A188420" target="_blank">Article</a>] </li><li id="reference-A187463">Yasir M, Sonthalia S: Corticosteroid Adverse Effects . [<a href="/articles/A187463" target="_blank">Article</a>] </li><li id="reference-A187439">Gardill BR, Vogl MR, Lin HY, Hammond GL, Muller YA: Corticosteroid-binding globulin: structure-function implications from species differences. PLoS One. 2012;7(12):e52759. doi: 10.1371/journal.pone.0052759. Epub 2012 Dec 26. [<a href="/articles/A187439" target="_blank">Article</a>] </li><li id="reference-A187436">Czock D, Keller F, Rasche FM, Haussler U: Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003. [<a href="/articles/A187436" target="_blank">Article</a>] </li><li id="reference-A188321">Sarkar U, Rivera-Burgos D, Large EM, Hughes DJ, Ravindra KC, Dyer RL, Ebrahimkhani MR, Wishnok JS, Griffith LG, Tannenbaum SR: Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab Dispos. 2015 Jul;43(7):1091-9. doi: 10.1124/dmd.115.063495. Epub 2015 Apr 29. [<a href="/articles/A188321" target="_blank">Article</a>] </li><li id="reference-L10529">FDA Approved Drug Products: Vosol Hydrocortisone and Glacial Acetic Acid Otic Drops [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/1997/012770s024lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L10532">FDA Approved Drug Products: Casporyn Neomycin Sulfate, Polymixin B Sulfate, and Hydrocortisone Otic Drops [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/060613s013lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L10535">FDA Approved Drug Products: Cortef Hydrocortisone Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/008697s036lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L10538">FDA Approved Drug Products: Cortenema Hydrocortisone Rectal Enema [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016199s035lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L7772">FDA Approved Drug Products: Bacitracin, Neomycin, Polymyxin B, and Hydrocortisone Topical Ointment [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L7321">FDA Approved Drug Products: Xerese (Acyclovir and Hydrocortisone) Topical Cream [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022436s004lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L10574">FDA Approved Drug Products: Hydrocortone Hydrocortisone Oral Tablets (Discontinued) [<a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=008506" target="_blank">Link</a>] </li><li id="reference-L16533">FDA Approved Drug Products: ALKINDI SPRINKLE (hydrocortisone) oral granules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213876s000lbl.pdf" target="_blank">Link</a>] </li></ol>